Apr 16, 2018 12:01 pm UTC| Business
Denver, CO, April 16, 2018 -- Medicine Man Technologies Inc. (OTCQB: MDCL) (“Medicine Man Technologies” or “Company”), one of the United States' leading cannabis branding and consulting companies today...
Apr 16, 2018 12:01 pm UTC| Business
CINCINNATI, OH LOS ANGELES, CA , April 16, 2018 -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the "Company" or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods...
XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology
Apr 16, 2018 12:01 pm UTC| Business
AUSTIN, Texas, April 16, 2018 -- XBiotech Inc. (NASDAQ:XBIT) announced today that it would evaluate a new subcutaneous formulation of the Company’s True Human™ monoclonal antibody, MABp1, in two separate Phase 2, open...
Extendicare Announces April 2018 Dividend of C$0.04 per Share
Apr 16, 2018 12:01 pm UTC| Business
MARKHAM, Ontario, April 16, 2018 -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month...
Apr 16, 2018 12:01 pm UTC| Business
CAMBRIDGE, Mass., April 16, 2018 -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for...
Introducing TraNexus - Blockchain ICO Announced, Ushering in New Era in Smarter Travel
Apr 16, 2018 12:01 pm UTC| Business
DUBLIN, Ireland and BRUSSELS, Belgium, April 16, 2018 -- Speaking today, Geoffrey Lipman, long time sustainable travel advocate, announced a new research and delivery program to advance application of the blockchain for...
Apr 16, 2018 12:00 pm UTC| Business
NEW HAVEN, Conn., April 16, 2018 -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today...